Clinical trials of disease-modifying agents in pediatric MS: Opportunities, challenges, and recommendations from the IPMSSG

OBJECTIVE: The impetus for this consensus discussion was to recommend clinical trial designs that can deliver high-quality data for effective therapies for pediatric patients, in a reasonable timeframe, with a key focus on short- and long-term safety. METHODS: The International Pediatric Multiple Sc...

Descripción completa

Detalles Bibliográficos
Autores principales: Waubant, Emmanuelle, Banwell, Brenda, Wassmer, Evangeline, Sormani, Maria-Pia, Amato, Maria-Pia, Hintzen, Rogier, Krupp, Lauren, Rostásy, Kevin, Tenembaum, Silvia, Chitnis, Tanuja
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6556085/
https://www.ncbi.nlm.nih.gov/pubmed/31043474
http://dx.doi.org/10.1212/WNL.0000000000007572

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6556085/
https://www.ncbi.nlm.nih.gov/pubmed/31043474
http://dx.doi.org/10.1212/WNL.0000000000007572

Ejemplares similares